Q2 2026 saw mixed market sentiment with strong North American growth offset by European weakness, leading to a 6% sales decline and lower earnings. Cost savings, cash flow, and net debt reduction progressed, while strategic transformation and sustainability initiatives advanced.Original document: H…
STOCKHOLM, July 17, 2026 /PRNewswire/ --Challenging market conditions in Europe, while solid growth in North AmericaSecond quarter 2026January – June 2026CEO CommentFollowing a solid start to the year, with strong sell-in to channel partners supported by successful product launches, trading conditi…
Earnings for the six months ended 30 June 2026 are expected to surge over 1300% year-over-year, driven by an 18% increase in PGM sales volumes and an 85% rise in PGM prices. Headline earnings per share are projected between 7047 and 8456 cents.Original document: Valterra Platinum Limited [VAL] Earn…
Net sales fell 23.1% year-over-year due to lower listing volumes and the rollout of 'Sell first, pay later,' while ARPL grew 12.4% and EBITDA margin declined to 46.4%. Strategic initiatives and AI-driven product innovation are being accelerated as the market shows early signs of recovery.Original d…
Underlying EBIT and profit for the period more than doubled year-over-year, driven by higher Nordic electricity prices, increased hydro and wind generation, and improved performance across all segments. Investments in renewables and grid infrastructure accelerated, while net debt and leverage ratio…
Record H1 2026 revenue of $8.3M marked 72% year-over-year growth, with gains across all segments and regions. FY 2026 revenue is now expected to exceed prior forecasts, with a small positive EBITDA anticipated.Original document: Itaconix plc [ITX] Earnings Release — Jul. 17 2026This is an AI-genera…
Q2 2026 saw 13% net sales growth and improved EBIT, driven by strong market activity and operational efficiency. Segment results were mixed, with Rock Sweden and Norway performing well, while Foundation Sweden faced margin pressure from investments and costs.Original document: Nordisk Bergteknik AB…
Lending and deposits grew modestly, but operating profit declined due to lower net interest and financial transaction results, as well as higher costs and imposed fees. Credit quality remains strong, capital ratios are robust, and the bank continues to invest in long-term competitiveness amid a rec…
RNS Number : 7669M Valterra Platinum Limited 17 July 2026 Trading StatementValterra Platinum Limited(Incorporated in the Republic of South Africa)(Registration number: 1946/022452/06)JSE Share Code: VALLSE Share Code: VALTJSE Debt Issuer Coder: VALIISIN: ZAE000013181("The Company" or "Valterra…
Revenue and profitability declined sharply year-over-year due to weak demand, especially in occupational health and public sector services, but cost adjustments and strategic acquisitions in eye care and dental services aim to support future growth. Guidance for 2026 was lowered, and leverage incre…
Record H1 2026 results with underlying EBITDA up 77.6% and fee paying AUM up 32.7% year-over-year. Fundraising reached €26bn towards a €28bn target, and the acquisition of Kayne Anderson Real Estate will add a fifth vertical and expand US presence. Exceptional costs impacted reported profit, but un…
Retail revenue grew 5% year-over-year to £455m, led by strong performance in Americas and Greater China, and double-digit growth in Outerwear. E-commerce and Gen Z customer acquisition drove momentum, while EMEIA faced headwinds from geopolitical issues.Original document: Burberry Group plc [BRBY…
Adjusted operating profit rose 6% year-over-year, with margin improvements in Sweden and positive profitability in Finland. Revenue declined 4% LTM, but the net debt ratio improved to 2.4% and the growth pipeline remains strong.Original document: Humana AB [HUM] Slides Release — Jul. 17 2026This is…
Transitioned to full consolidation and a non-going concern basis, focusing on asset realisation and capital return. Net loss of $46.1m driven by vessel impairments; $381.1m raised from 23 vessel sales. Debt fully repaid, strong liquidity, and robust governance support an orderly wind-down and furth…
Order intake and net sales grew strongly in Q2 2026, with adjusted EBIT up 22% and profit rising 18%. Strategic initiatives focus on core business, cost savings, and production expansion, while risks from inflation and global uncertainty remain.Original document: engcon AB Class B [ENGCON_B] Interi…
A managed wind-down led to 23 vessel sales, full bank debt repayment, and significant capital returns. Net charter revenue was $113.9 million, with a $46.1 million loss driven by vessel impairments. Most proceeds from asset sales are expected to be distributed by year-end.Original document: Taylor…
Net sales grew 12% in Q2 2026 excluding currency effects, with strong gains in both Pediatrics and Adult Health segments. Adjusted operating profit rose 32%, and the company maintained high margins and robust cash flow, despite APAC softness. Dividend of SEK 404.6 million was paid.Original document…
Revenue nearly doubled year-over-year in H1 2026, with strong EBITDA and improved margins. Major international orders and partnerships, a successful rights issue, and a ramp-up in production capacity support a positive outlook amid favorable industry trends.Original document: Midsummer AB [MIDS] In…
Net sales and operating profit saw strong double-digit growth in both Q2 and H1, driven by acquisitions and organic expansion, with improved margins and robust cash flow. Leverage remains within target, and four acquisitions contributed significantly to results.Original document: Roko AB Class B [R…
STOCKHOLM, July 17, 2026 /PRNewswire/ --April – JuneCEO commentsWe delivered exceptionally strong order intake in the quarter, demonstrating the strength of our offering and the continued high level of activity in our key markets. However, profitability is currently affected by the planned ramp-up…
